\-\ Texto\\:\\ \ \(0\)\
\-\ mastectomy\\.\ \(18\)\
\-\ breast\\ mri\\ demonstrates\\ soft\\ tissue\\ mass\\ in\\ right\\ breast\\ sub\\-\\ areolar\\ region\\.\ \(0\)\
\-\ lymphoscintigraphy\\ identified\\ two\\ nodular\\ hot\\ foci\\ superior\\ to\\ the\\ the\\ right\\ periareolar\\ injection\\ site\\ and\\ two\\ nodular\\ foci\\ more\\ in\\ the\\ right\\ infraclavicular\\ region\\.\ \(0\)\
\-\ infiltrating\\ breast\\ cancer\ \(0\)\
\-\ breast\\ cancer\ \(149\)\
\-\ inflammatory\\ reaction\ \(4\)\
\-\ woman\\ presents\\ with\\ breast\\ lump\\.\\ biopsy\\ proven\\ infiltrating\\ ductal\\ carcinoma\\ in\\ left\\ breast\\.\\ \\ she\\ undergoes\\ left\\ breast\\ total\\ mastectomy\\ with\\ reconstruction\\ in\\ left\\ and\\ augmentation\\ of\\ right\\.\\ \\ she\\ presents\\ for\\ follow\\-up\\ mammogram\\ and\\ a\\ ill\\-defined\\ right\\ breast\\ nodular\\ density\\ is\\ identified\\.\\ \\ pre\\-operative\\ planning\\ included\\ intraoperative\\ sentinal\\ node\\ biopsy\\ and\\ bilateral\\ breast\\ mastectomies\\.\ \(0\)\
\-\ lymphoscintigraphy\\ is\\ a\\ valuable\\ tool\\ that\\ is\\ currently\\ being\\ investigated\\ to\\ localize\\ sentinel\\ lymph\\ nodes\\ in\\ breast\\ cancer\\.\\ \\ axillary\\ node\\ disection\\ is\\ still\\ the\\ standard\\ of\\ care\\ due\\ to\\ skip\\ metastisis\\.\\ \\ axillary\\ node\\ disection\\ has\\ significant\\ morbidity\\ to\\ include\\ lymphoedema\\ and\\ moderate\\ to\\ severe\\ pain\\.\\ \\ lymphoscintigraphy\\ sensitivity\\ increases\\ with\\ combined\\ imaging\\,\\ intraoperative\\ gamma\\ ray\\ dectors\\,\\ and\\ blue\\ dye\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.5055890112906656\ \(0\)\
\-\ lymphoscintigraphy\\:\\ 0\\.30865122824888247\ \(0\)\
\-\ disection\\:\\ 0\\.21279002684805035\ \(0\)\
\-\ node\\:\\ 0\\.1795294565105994\ \(0\)\
\-\ nodular\\:\\ 0\\.16633501928072242\ \(0\)\
\-\ intraoperative\\:\\ 0\\.16103275804638073\ \(0\)\
\-\ mastectomy\\:\\ 0\\.14779420367864002\ \(0\)\
\-\ cancer\\:\\ 0\\.13912344364362345\ \(0\)\
\-\ axillary\\:\\ 0\\.13696820948806415\ \(0\)\
\-\ infiltrating\\:\\ 0\\.13660656181351352\ \(0\)\
\-\ right\\:\\ 0\\.11541611979687615\ \(0\)\
\-\ foci\\:\\ 0\\.11381217661698888\ \(0\)\
\-\ metastisis\\:\\ 0\\.11134387148618444\ \(0\)\
\-\ lymphoedema\\:\\ 0\\.11134387148618444\ \(0\)\
\-\ dectors\\:\\ 0\\.11134387148618444\ \(0\)\
\-\ infraclavicular\\:\\ 0\\.10639501342402517\ \(0\)\
\-\ areolar\\:\\ 0\\.10288374274962749\ \(0\)\
\-\ periareolar\\:\\ 0\\.10288374274962749\ \(0\)\
\-\ sentinal\\:\\ 0\\.10288374274962749\ \(0\)\
\-\ dye\\:\\ 0\\.10288374274962749\ \(0\)\
\-\ mastectomies\\:\\ 0\\.10016018962296588\ \(0\)\
\-\ identified\\:\\ 0\\.09872266969164561\ \(0\)\
\-\ biopsy\\:\\ 0\\.0976078288559664\ \(0\)\
\-\ investigated\\:\\ 0\\.09605341617292726\ \(0\)\
\-\ skip\\:\\ 0\\.09442361401307053\ \(0\)\
\-\ undergoes\\:\\ 0\\.09053676337375427\ \(0\)\
\-\ valuable\\:\\ 0\\.08947475595091127\ \(0\)\
\-\ tool\\:\\ 0\\.0875932874363703\ \(0\)\
\-\ sentinel\\:\\ 0\\.0875932874363703\ \(0\)\
\-\ to\\:\\ 0\\.08702926795918613\ \(0\)\
\-\ in\\:\\ 0\\.08660091008253482\ \(0\)\
\-\ and\\:\\ 0\\.08632163534263013\ \(0\)\
\-\ augmentation\\:\\ 0\\.08596348527651358\ \(0\)\
\-\ localize\\:\\ 0\\.08386598659544639\ \(0\)\
\-\ region\\:\\ 0\\.08329181361526666\ \(0\)\
\-\ she\\:\\ 0\\.0828909709214182\ \(0\)\
\-\ two\\:\\ 0\\.08269299115374673\ \(0\)\
\-\ hot\\:\\ 0\\.08051637902319037\ \(0\)\
\-\ planning\\:\\ 0\\.07913315869981334\ \(0\)\
\-\ blue\\:\\ 0\\.07913315869981334\ \(0\)\
\-\ is\\:\\ 0\\.07626797943883601\ \(0\)\
\-\ gamma\\:\\ 0\\.07508881702668299\ \(0\)\
\-\ morbidity\\:\\ 0\\.07477980341329502\ \(0\)\
\-\ increases\\:\\ 0\\.07307395499015072\ \(0\)\
\-\ lump\\:\\ 0\\.07281146345890452\ \(0\)\
\-\ reconstruction\\:\\ 0\\.0723028321231131\ \(0\)\
\-\ left\\:\\ 0\\.07125075521453664\ \(0\)\
\-\ sensitivity\\:\\ 0\\.07067302996325639\ \(0\)\
\-\ proven\\:\\ 0\\.07024472686765812\ \(0\)\
\-\ combined\\:\\ 0\\.06904322780339966\ \(0\)\
\-\ presents\\:\\ 0\\.06698543857368199\ \(0\)\
\-\ mammogram\\:\\ 0\\.06647320356613379\ \(0\)\
\-\ standard\\:\\ 0\\.06461382625359377\ \(0\)\
\-\ still\\:\\ 0\\.061679830227966775\ \(0\)\
\-\ ductal\\:\\ 0\\.06126952652476712\ \(0\)\
\-\ injection\\:\\ 0\\.06058309906684272\ \(0\)\
\-\ included\\:\\ 0\\.06020751910192412\ \(0\)\
\-\ reaction\\:\\ 0\\.05923056697641208\ \(0\)\
\-\ nodes\\:\\ 0\\.05914551167908113\ \(0\)\
\-\ ray\\:\\ 0\\.05755816307775972\ \(0\)\
\-\ total\\:\\ 0\\.05704801299801394\ \(0\)\
\-\ site\\:\\ 0\\.05615369751703681\ \(0\)\
\-\ the\\:\\ 0\\.055570012415568484\ \(0\)\
\-\ lymph\\:\\ 0\\.05414027760087881\ \(0\)\
\-\ currently\\:\\ 0\\.053483326983336306\ \(0\)\
\-\ moderate\\:\\ 0\\.05226684687772054\ \(0\)\
\-\ care\\:\\ 0\\.04974761346951863\ \(0\)\
\-\ being\\:\\ 0\\.04851671562964914\ \(0\)\
\-\ inflammatory\\:\\ 0\\.04707912824188755\ \(0\)\
\-\ density\\:\\ 0\\.046167855480821425\ \(0\)\
\-\ superior\\:\\ 0\\.045265429950174234\ \(0\)\
\-\ severe\\:\\ 0\\.044074979176546285\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04164590680763333\ \(0\)\
\-\ include\\:\\ 0\\.04142562315238188\ \(0\)\
\-\ with\\:\\ 0\\.0408997262208574\ \(0\)\
\-\ significant\\:\\ 0\\.04019934157042428\ \(0\)\
\-\ due\\:\\ 0\\.04002115759165897\ \(0\)\
\-\ more\\:\\ 0\\.03823100161603379\ \(0\)\
\-\ bilateral\\:\\ 0\\.037418486057883234\ \(0\)\
\-\ soft\\:\\ 0\\.03706631547083043\ \(0\)\
\-\ imaging\\:\\ 0\\.03658974795969338\ \(0\)\
\-\ tissue\\:\\ 0\\.03652316085633309\ \(0\)\
\-\ woman\\:\\ 0\\.03626038675049178\ \(0\)\
\-\ mri\\:\\ 0\\.03573876405022367\ \(0\)\
\-\ demonstrates\\:\\ 0\\.034978321118917965\ \(0\)\
\-\ has\\:\\ 0\\.03180219690317026\ \(0\)\
\-\ that\\:\\ 0\\.030214188247998354\ \(0\)\
\-\ of\\:\\ 0\\.02725020215794226\ \(0\)\
\-\ mass\\:\\ 0\\.02659449463377291\ \(0\)\
\-\ pain\\:\\ 0\\.024914015648195936\ \(0\)\
\-\ for\\:\\ 0\\.021102488363852038\ \(0\)\
